Singapore, July 15 -- The Health Sciences Authority received information related to the study titled 'DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE 3 STUDY TO EVALUATE THE EFFICACY AND SAFETY OF PLOZASIRAN ... और पढ़ें
Singapore, July 15 -- The Health Sciences Authority received information related to the study titled 'A Phase 3 Randomized, Open-label Study of Rinatabart Sesutecan (Rina-S) versus Treatment of Invest... और पढ़ें
Singapore, July 15 -- The Health Sciences Authority received information related to the study titled 'A Phase III, Randomized, Open-Label, Multicenter, Global Study of Puxitatug Samrotecan (AZD8205) M... और पढ़ें
U.S., July 15 -- ClinicalTrials.gov registry received information related to the study (NCT07703215) titled 'NPQ Plus Supplementation for Skin Health and Antioxidant Status' on July 08. Brief Summary... और पढ़ें
Singapore, July 15 -- The Health Sciences Authority received information related to the study titled 'A Multicenter, Randomized, Double-blind, Phase 2/3 Study of Ficerafusp Alfa (BCA101) or Placebo in... और पढ़ें
Singapore, July 15 -- The Health Sciences Authority received information related to the study titled 'Safety, immunogenicity and efficacy of low dose Nivolumab in adults living with HIV on antiretrovi... और पढ़ें
U.S., July 15 -- ClinicalTrials.gov registry received information related to the study (NCT07703761) titled 'AI-driven Processing and Analysis of Glioma Imaging Data' on July 09. Brief Summary: GLIOM... और पढ़ें
Singapore, July 15 -- The Health Sciences Authority received information related to the study titled 'A Phase I, Randomized, Double-Blind, Placebo-Controlled, Single- and Multiple-Ascending Dose Study... और पढ़ें
Singapore, July 15 -- The Health Sciences Authority received information related to the study titled 'Antigen Targeted T cell therapy for Relapsed/Refractory B cell Lymphomas'. The following are the o... और पढ़ें
Singapore, July 15 -- The Health Sciences Authority received information related to the study titled 'DAREON®-Lung 1: A Phase III multi-center, open-label, randomised trial of intravenous obrixtamig i... और पढ़ें